Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) will issue its quarterly earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($1.73) per share for the quarter. Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The biopharmaceutical company […]
Related Keywords
United States , Japan , Canada , America , Matthewk Fust , , Cantor Fitzgerald , Royal Bank , Ultragenyx Pharmaceutical Inc , Canaccord Genuity Group , Nasdaq , Ultragenyx Pharmaceutical Company Profile , Jpmorgan Chase Co , Ultragenyx Pharmaceutical , Get Free Report , John Richard Pinion , Director Matthew , Pharmaceutical Inc , North America , Latin America , Ultragenyx Pharmaceutical Daily , Nasdaq Rare , Rare , Medical , Earnings ,
vimarsana.com © 2020. All Rights Reserved.